Lasting response after discontinuation of cemiplimab in a patient with locally advanced basal cell carcinoma
De Giorgi V., Trane L., Savarese I., Silvestri F., Venturi F., Zuccaro B., et al. (2021). Lasting response after discontinuation of cemiplimab in a patient with locally advanced basal cell carcinoma. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 46(8), 1612-1614 [10.1111/ced.14804].
Lasting response after discontinuation of cemiplimab in a patient with locally advanced basal cell carcinoma
Venturi F.;
2021
Abstract
Lasting response after discontinuation of cemiplimab in a patient with locally advanced basal cell carcinomaFile in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.